The concept of virtual screening and automated de novo design has been corroborated as a viable strategy for scaffold hopping from bioactive natural products to isofunctional, synthetically accessible mimetics.
No takes yet. Share an insight, caveat, or question.
Merk et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: